OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
4.040
+0.010 (0.25%)
At close: Oct 22, 2024, 4:00 PM
4.060
+0.020 (0.50%)
After-hours: Oct 22, 2024, 4:00 PM EDT
OmniAb Revenue
OmniAb had revenue of $7.61M in the quarter ending June 30, 2024, with 9.62% growth. This brings the company's revenue in the last twelve months to $21.71M, down -67.16% year-over-year. In the year 2023, OmniAb had annual revenue of $34.16M, down -42.17%.
Revenue (ttm)
$21.71M
Revenue Growth
-67.16%
P/S Ratio
18.71
Revenue / Employee
$204,849
Employees
106
Market Cap
477.38M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 34.16M | -24.91M | -42.17% |
Dec 31, 2022 | 59.08M | 24.33M | 70.02% |
Dec 31, 2021 | 34.75M | 11.48M | 49.34% |
Dec 31, 2020 | 23.27M | 4.95M | 27.02% |
Dec 31, 2019 | 18.32M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Ginkgo Bioworks Holdings | 184.34M |
SIGA Technologies | 172.96M |
National Research | 146.28M |
Quanterix | 129.33M |
Alector | 55.28M |
Verve Therapeutics | 20.65M |
MeiraGTx Holdings | 8.12M |
Absci | 3.25M |
OABI News
- 2 months ago - OmniAb to Participate in Two Investor Conferences in September - Business Wire
- 2 months ago - OmniAb, Inc. (OABI) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - OmniAb Reports Second Quarter 2024 Financial Results and Business Highlights - Business Wire
- 2 months ago - Long Assets On Path To Creating Significant Value, Shorting Remains Very Challenging - Seeking Alpha
- 3 months ago - OmniAb to Report Second Quarter 2024 Financial Results on August 8 - Business Wire
- 5 months ago - OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology - Business Wire
- 5 months ago - OmniAb to Participate in the Jefferies Global Healthcare Conference - Business Wire
- 5 months ago - OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit - Business Wire